Sustained Intraocular Pressure Rise after the Treat and Extend Regimen at 3 Years: Aflibercept versus Ranibizumab.

Bilgic, Alper; Kodjikian, Laurent; Chhablani, Jay; Sudhalkar, Anand; Trivedi, Megha; Vasavada, Viraj; Vasavada, Vaishali; Vasavada, Shail; Srivastava, Samaresh; Bhojwani, Deepak; Sudhalkar, Aditya

Bilgic, Alper; Kodjikian, Laurent; Chhablani, Jay; Sudhalkar, Anand; Trivedi, Megha; Vasavada, Viraj; Vasavada, Vaishali; Vasavada, Shail; Srivastava, Samaresh; Bhojwani, Deepak; Sudhalkar, Aditya.

Afiliación

Bilgic A; Alpha Vision Augenzentrum, Bremerhaven, Germany.
Kodjikian L; Hospices Civil de la Croix Rousse, Lyon, France.
Chhablani J; Pittsburgh Medical Centre, Pittsburgh, PA, USA.
Sudhalkar A; M. S. Sudhalkar Medical Research Foundation, Baroda, India.
Trivedi M; M. S. Sudhalkar Medical Research Foundation, Baroda, India.
Vasavada V; Raghudeep Eye Hospital, Ahmedabad, India.
Vasavada V; Raghudeep Eye Hospital, Ahmedabad, India.
Vasavada S; Raghudeep Eye Hospital, Ahmedabad, India.
Srivastava S; Raghudeep Eye Hospital, Ahmedabad, India.
Bhojwani D; Raghudeep Eye Hospital, Ahmedabad, India.
Sudhalkar A; Alpha Vision Augenzentrum, Bremerhaven, Germany.

J Ophthalmol ; 2020: 7462098, 2020.

Article en En | MEDLINE | ID: mdl-32051764

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Guideline / Risk_factors_studies Idioma: En Revista: J Ophthalmol Año: 2020 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google